Chronic Kidney Disease Stocks List

Related ETFs - A few ETFs which own one or more of the above listed Chronic Kidney Disease stocks.

Chronic Kidney Disease Stocks Recent News

Date Stock Title
Nov 1 SNY Vir Biotechnology Inc (VIR) Q3 2024 Earnings Call Highlights: Strategic Restructuring and ...
Nov 1 LSTA Lisata Therapeutics, Inc. (LSTA) Upgraded to Buy: Here's What You Should Know
Nov 1 SNY Kymera Q3 Loss Narrower Than Expected, Pipeline in Focus
Nov 1 ARDX Q3 2024 Ardelyx Inc Earnings Call
Nov 1 AKBA Akebia Therapeutics to Report Third Quarter 2024 Financial Results and Discuss Recent Business Highlights
Nov 1 OPK Waters (WAT) Beats Q3 Earnings and Revenue Estimates
Nov 1 ARDX Ardelyx Inc (ARDX) Q3 2024 Earnings Call Highlights: Revenue Surge and Strategic Growth Amidst ...
Nov 1 SNY Kymera Therapeutics Inc (KYMR) Q3 2024 Earnings Call Highlights: Strategic Advancements and ...
Nov 1 AZN U.S. Drugmakers Are Breaking Up With Their Chinese Supply-Chain Partners
Nov 1 ARDX Ardelyx, Inc. (ARDX) Q3 2024 Earnings Call Transcript
Oct 31 ARDX Compared to Estimates, Ardelyx (ARDX) Q3 Earnings: A Look at Key Metrics
Oct 31 ARDX Ardelyx (ARDX) Reports Break-Even Earnings for Q3
Oct 31 ARDX Ardelyx Beats Q3 Sales Estimates, Shares Climb
Oct 31 ARDX Ardelyx: Q3 Earnings Snapshot
Oct 31 ARDX Ardelyx GAAP EPS of $0.00 beats by $0.05, revenue of $98.24M beats by $11.6M
Oct 31 ARDX Ardelyx Reports Third Quarter 2024 Financial Results and Provides Business Update
Oct 31 AZN AstraZeneca Probe in China Adds to Concerns for Foreign Businesses
Oct 31 SNY REGN Q3 Earnings and Revenues Beat on Strong Eylea HD & Dupixent Sales
Oct 31 LSTA Lisata Therapeutics to Participate in Upcoming November 2024 Industry and Investor Events
Oct 31 AZN 3 Rock-Solid Dividend Stocks You Can Buy and Hold Forever
Chronic Kidney Disease

Chronic kidney disease (CKD) is a type of kidney disease in which there is gradual loss of kidney function over a period of months or years. Early on there are typically no symptoms. Later, leg swelling, feeling tired, vomiting, loss of appetite, or confusion may develop. Complications may include heart disease, high blood pressure, bone disease, or anemia.Causes of chronic kidney disease include diabetes, high blood pressure, glomerulonephritis, and polycystic kidney disease. Risk factors include a family history of the condition. Diagnosis is generally by blood tests to measure the glomerular filtration rate and urine tests to measure albumin. Further tests such as an ultrasound or kidney biopsy may be done to determine the underlying cause. A number of different classification systems exist.Screening at-risk people is recommended. Initial treatments may include medications to manage blood pressure, blood sugar, and lower cholesterol. NSAIDs should be avoided. Other recommended measures include staying active and certain dietary changes. Severe disease may require hemodialysis, peritoneal dialysis, or a kidney transplant. Treatments for anemia and bone disease may also be required.Chronic kidney disease affected 753 million people globally in 2016, including 417 million females and 336 million males. In 2015 it resulted in 1.2 million deaths, up from 409,000 in 1990. The causes that contribute to the greatest number of deaths are high blood pressure at 550,000, followed by diabetes at 418,000, and glomerulonephritis at 238,000.

Browse All Tags